This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 7 from Patent US 20030077289
General Information
DRACP ID DRACP01230
Peptide Name Sequence 7 from Patent US 20030077289
Sequence AAVALLPAVLLALLAP
Sequence Length 16
UniProt ID P08620
PubChem CID Not available
Origin Human
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C74H130N16O17
Absent amino acids CDEFGHIKMNQRSTWY
Common amino acids AL
Mass 178372
Pl 6.11
Basic residues 0
Acidic residues 0
Hydrophobic residues 14
Net charge 0
Boman Index 4846
Hydrophobicity 242.5
Aliphatic Index 220
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2003/0077289 A1
Patent Title Use of cell-penetrating peptides to generate antitumor immunity.
Other Iinformation Granted Patent Family: 6s / 6ex; Family Jurisdictions: CN, WO, AU, US; Legal Status: Discontinued; Application No: 7755502; Filed:Feb 15, 2002; Published: Apr 24, 2003; Earliest Priority: Feb 15, 2001
Other Published ID CN1309417C CN1503628A WO2002064057A2 WO2002064057A3
This work is licensed under a Creative Commons Attribution 4.0 International License.